We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
-13.75%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$713M
AUM Growth
-$97.1M
Cap. Flow
+$15.7M
Cap. Flow %
2.2%
Top 10 Hldgs %
21.39%
Holding
340
New
71
Increased
82
Reduced
98
Closed
62

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$22.8M
2
KSS icon
Kohl's
KSS
+$17.8M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$13.5M
4
WFM
Whole Foods Market Inc
WFM
+$12.2M
5
STJ
St Jude Medical
STJ
+$11.7M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$20.9M
2
RCL icon
Royal Caribbean
RCL
+$19.5M
3
LOW icon
Lowe's Companies
LOW
+$14.5M
4
MSFT icon
Microsoft
MSFT
+$14.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.9M

Sector Composition

Rank Sector Weight
1 Financials 19.4%
2 Technology 15.43%
3 Healthcare 14.56%
4 Consumer Discretionary 14.04%
5 Industrials 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRRX
226
DELISTED
DURECT Corp
DRRX
$387K 0.05%
+19,861
New +$452K
MCHB
227
Mechanics Bancorp
MCHB
$3.7B
$379K 0.05%
+16,400
New +$370K
CERS icon
228
Cerus
CERS
$504M
$371K 0.05%
81,642
-1,175
-1% -$6.08K
CTG
229
DELISTED
Computer Task Group, Inc.
CTG
$370K 0.05%
59,754
+577
+1% +$3.97K
VSTM icon
230
Verastem
VSTM
$605M
$364K 0.05%
16,935
+6,937
+69% +$549K
ECOM
231
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$364K 0.05%
36,580
-22,553
-38% -$248K
NBSE
232
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$352K 0.05%
319
-5
-2% -$5.79K
CB
233
DELISTED
CHUBB CORPORATION
CB
$337K 0.05%
2,745
– –
FCSC
234
DELISTED
Fibrocell Science Inc.
FCSC
$331K 0.05%
5,734
-338
-6% -$29.9K
SKUL
235
DELISTED
SKULLCANDY INC
SKUL
$330K 0.05%
+59,714
New +$420K
AKBA icon
236
Akebia Therapeutics
AKBA
$236M
$323K 0.05%
33,406
-300
-0.9% -$2.75K
AIG icon
237
American International
AIG
$40.6B
$319K 0.04%
5,608
– –
CBI
238
DELISTED
Chicago Bridge & Iron Nv
CBI
$308K 0.04%
7,774
– –
VAL
239
DELISTED
Valspar
VAL
$299K 0.04%
4,164
– –
ECYT
240
DELISTED
Endocyte, Inc. Common Stock
ECYT
$295K 0.04%
64,392
-800
-1% -$4.19K
SHLM
241
DELISTED
Schulman (A.) Inc
SHLM
$292K 0.04%
9,000
– –
ASRT
242
DELISTED
Assertio
ASRT
$288K 0.04%
254
-666
-72% -$1.14M
ZSPH
243
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$277K 0.04%
4,216
-5,204
-55% -$312K
AVP
244
DELISTED
Avon Products, Inc.
AVP
$274K 0.04%
84,203
– –
LUV icon
245
Southwest Airlines
LUV
$22B
$269K 0.04%
7,076
– –
TIS
246
DELISTED
Orchids Paper Products, Inc.
TIS
$267K 0.04%
+10,232
New +$258K
AXDX
247
DELISTED
Accelerate Diagnostics
AXDX
$263K 0.04%
+1,628
New +$352K
DEST
248
DELISTED
Destination Maternity Corporation
DEST
$256K 0.04%
27,777
-400
-1% -$4.27K
OMN
249
DELISTED
OMNOVA Solutions Inc.
OMN
$246K 0.03%
44,469
-700
-2% -$4.49K
XEL icon
250
Xcel Energy
XEL
$47.8B
$241K 0.03%
6,800
– –
8 9
10
11 12

Similar funds

HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
FHC
Forest Hill Capital Little Rock, Arkansas $152M AUM 64.38% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return

Stoneridge Investment Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Stoneridge Investment Partners held 340 positions worth $713M, down 12% from $810M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Stoneridge Investment Partners's Q3 2015 filing shows 71 new, 82 increased, 98 reduced and 62 closed positions. Its largest new stake was Viatris: 408,857 shares worth $16.5M. The largest sale was Johnson & Johnson, an estimated $20.9M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Stoneridge Investment Partners's largest Q3 2015 buy was Viatris: 408,857 shares worth $16.5M.
  • Stoneridge Investment Partners added most to Kohl's in Q3 2015, an estimated $17.8M increase.
  • Stoneridge Investment Partners's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $20.9M.
  • Stoneridge Investment Partners fully exited Teva Pharmaceuticals in Q3 2015, selling an estimated $8.7M.
  • Stoneridge Investment Partners's ten largest holdings make up 21% of its $713M portfolio in Q3 2015.
  • Stoneridge Investment Partners opened 71 new positions and closed 62 in Q3 2015.
  • Stoneridge Investment Partners's portfolio value fell 12% quarter-over-quarter to $713M.

Based on Stoneridge Investment Partners's 13F filing for Q3 2015, filed 26 Oct 2015.